Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM4 | P08173 | 2/20 | 0.37 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 4/20 | 0.33 |
| ▸ | HTR2B | P41595 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.31 |
| ▸ | MRGPRX2 | Q96LB1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL933180 | 0.92 | HRH3 (0.38) | CHRM4CHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL5331154 | 0.64 | HTR2A (0.33) | HTR2CALDH1A1 | |
| SCHEMBL189065 | 0.62 | HRH3 (0.53) | CHRM4CHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL10262302 | 0.61 | SMN1; SMN2 (0.59) | CHRM4CHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL14578240 | 0.61 | HRH3 (0.56) | CHRM4CHRM5CHRM1CHRM3HTR2C | |
| SCHEMBL714763 | 0.61 | SMN1; SMN2 (0.59) | CHRM4CHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL10261345 | 0.61 | SMN1; SMN2 (0.59) | CHRM4CHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL932866 | 0.61 | CHRM4 (0.40) | CHRM4CHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL14892879 | 0.60 | HTR2C (0.43) | CHRM4CHRM5CHRM1CHRM3CHRM2 | |
| SCHEMBL27002979 | 0.60 | HTR2C (0.43) | CHRM4CHRM5CHRM1CHRM3CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2451802-A1 | PYRIMIDINYL AND 1,3,5-TRIAZINYL BENZIMIDAZOLES AND THEIR USE IN CANCER THERAPY | Pathway Therapeutics, Inc. (US) | 2012-05-16 | — | — | EP | disclosed |
| WO-2011005119-A1 | PYRIMIDINYL AND 1,3,5-TRIAZINYL BENZIMIDAZOLES AND THEIR USE IN CANCER THERAPY | PATHWAY THERAPEUTICS LIMITED (NZ) | 2011-01-13 | — | — | WO | disclosed |